Clinical/scientific notes

Neurology

Volumn 79, Issue 22, 2012, Pages 2214-2216

  Rigau, Valérie ^a   Mania, Alexandre ^d   Béfort, Patrice ^b   Carlander, Bertrand ^c   Jonquet, Olivier ^b   Lassmann, Hans ^e   Camu, William ^c   Thouvenot, Eric ^f  

^a Service d'Anatomopathologie   (France)

^b Département de Réanimation Médicale   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d CH de Beziers   (France)

^e Medical University of Vienna   (Austria)

^f NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; GADOLINIUM; METHYLPREDNISOLONE; MITOXANTRONE; NATALIZUMAB; MONOCLONAL ANTIBODY;

ADULT; ATAXIA; AUTOPSY; BRAIN DISEASE; BULBAR PARALYSIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; DEPRESSION; DISEASE SEVERITY; DRUG WITHDRAWAL; EXPANDED DISABILITY STATUS SCALE; FATIGUE; HOSPITALIZATION; HUMAN; MALE; MORTALITY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROPATHOLOGY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PARESIS; PLASMAPHERESIS; PRIORITY JOURNAL; QUADRIPLEGIA; RELAPSE; REMISSION; TREATMENT REFUSAL; ARTICLE; DRUG COMBINATION; FATALITY; IMMUNOLOGY; METHODOLOGY; PATHOLOGY; RECURRENT DISEASE; WITHDRAWAL SYNDROME;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; DRUG THERAPY, COMBINATION; FATAL OUTCOME; HUMANS; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84871261732     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318275979d     Document Type: Article

References (7)

1. Sorensen PS, Bertolotto A, Edan G, et al. Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. Mult Scler 2012;18:143-152.
2. Lenhard T, Biller A, Mueller W, Metz I, Schonberger J, Wildemann B. Immune reconstitution inflammatory syndrome after withdrawal of natalizumab? Neurology 2010;75:831-833.
3. Kerbrat A, Le Page E, Leray E, et al. Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patients. J Neurol Sci 2011;308:98-102.
4. Martin-Blondel G, Delobel P, Blancher A, et al. Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV. Brain 2011;134:928-946.
5. Lucchinetti CF, Gavrilova RH, Metz I, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 2008;131:1759-1775.
6. Metz I, Radue EW, Oterino A, et al. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol 2012;123:235-245.
7. O'Connor PW, Goodman A, Kappos L, et al. Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology 2011;76:1858-1865.